FDA Approves First Strattera Generic for ADHD, Plus Five Other First-Time Generics

Drug Industry Daily
A A
The FDA approved the first generic versions of Strattera (atomoxetine) to treat attention-deficit hyperactivity disorder in pediatric and adult patients, including multiple strengths manufactured by Apotex, Teva, Aurobindo Pharma and Glenmark Pharmaceuticals.

To View This Article:

Login

Subscribe To Drug Industry Daily